HLL Lifecare, a mini-ratna public sector undertaking with diversified business, is foraying into molecular diagnostics area with a duplex test kit to make chikungunya and dengue fever tests more affordable to the common man.
The new multiplex molecular diagnostic kit, which is based on PCR (polymerase chain reaction), has been developed by HLL in collaboration with the Rajiv Gandhi Centre for Biotechnology, also based in Thiruvananthapuram.
Currently, HLL Lifecare is in a tie-up with Kerala State Institute for Virology and Infectious Diseases, under the state government’s Ministry of Health and Family Welfare Department, for third-party validation of the diagnostic kits. The product will be launched in the market very soon.
“Making public healthcare affordable has always been our motto,” said HLL Chairman and Managing Director Dr M Ayyappan. “This kit comes as the latest offering from our portfolio to ease the burden of the common man.”
Further, the new product would facilitate conduct of the test with large throughput screening for management of diseases, he noted. “It is going to be a handy tool in screening of patients on a large scale basis in an affordable manner.’’
“Looking to tap the growing opportunities in the sector and making a solid market intervention to make tests of communicable diseases accessible and affordable, we will extend the facility for other viral platforms as well,” Dr Ayyappan added. The 1966-founded HLL provides a complete range of path lab services.
EH News Bureau
- Advertisement -
